Efficacy and Safety of AAE581 in Postmenopausal Women With Osteopenia/Osteoporosis.

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2005
AAE581 is a specific inhibitor of the cysteine protease cathepsin K. This trial is designed to provide detailed information about the effects( efficacy and safety) of AAE581 on Bone Mineral Density.
Epistemonikos ID: 8686590e09e73d841dfd10ebea2f6984d03ba923
First added on: May 04, 2024